Literature DB >> 4178231

Studies into the occurrence of soluble antigen-antibody complexes in disease. II. Criteria for distinguishing soluble complexes from other macromolecular histamine releasers.

I Broder, R Baumal, E Keystone.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 4178231      PMCID： PMC1578943     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  17 in total

1.  LIVER LOCALIZING ANTIBODIES--THE LIMITED CONTRIBUTION OF AG-AB COMPLEXES.

Authors:  D SULITZEANU; Y YAGI; D PRESSMAN
Journal:  J Immunol       Date:  1964-05       Impact factor: 5.422

2.  The mechanism of anaphylaxis: specificity of antigen-induced mast cell damage in anaphylaxis in the guinea pig.

Authors:  J H HUMPHREY; I MOTA
Journal:  Immunology       Date:  1959-01       Impact factor: 7.397

3.  Stimulating action of soluble antigen-antibody complexes on normal guinea-pig smooth muscle.

Authors:  I L TRAPANI; J S GARVEY; D H CAMPBELL
Journal:  Science       Date:  1958-03-28       Impact factor: 47.728

4.  The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis.

Authors:  C M PLOTZ; J M SINGER
Journal:  Am J Med       Date:  1956-12       Impact factor: 4.965

5.  Activation of a histamine-releasing agent (anaphylatoxin) in normal rat plasma.

Authors:  A M ROTHSCHILD; M ROCHA E SILVA
Journal:  Br J Exp Pathol       Date:  1954-10

6.  Histamine release from the perfused lung of the guinea pig by serotoxin, anaphylatoxin.

Authors:  M ROCHA E SILVA; M ARONSON
Journal:  Br J Exp Pathol       Date:  1952-12

7.  Studies into the occurrence of soluble antigen-antibody complexes in disease. 3. Rheumatoid arthritis and other human diseases.

Authors:  R Baumal; I Broder
Journal:  Clin Exp Immunol       Date:  1968-07       Impact factor: 4.330

8.  Studies into the occurrence of soluble antigen--antibody complexes in disease. I. A biological assay for soluble complexes.

Authors:  R Baumal; I Broder
Journal:  Clin Exp Immunol       Date:  1968-07       Impact factor: 4.330

9.  Anaphylactoid reaction to human gamma globulin. Report of a case and inquiry into mechanism.

Authors:  H B Richerson; P M Seebohm
Journal:  Arch Intern Med       Date:  1966-04

10.  Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.

Authors:  W Dias Da Silva; I H Lepow
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307
View more
  7 in total

1.  Mechanism of histamine release from guinea-pig lung by soluble immune complexes. II. Role of anaphylatoxin.

Authors:  I Broder
Journal:  Immunology       Date:  1974-01       Impact factor: 7.397

2.  Studies of reversed anaphylaxis in the perfused guinea-pig lung.

Authors:  I Broder; R Baumal
Journal:  Immunology       Date:  1972-04       Impact factor: 7.397

3.  Studies into the occurrence of soluble antigen-antibody complexes in disease. 3. Rheumatoid arthritis and other human diseases.

Authors:  R Baumal; I Broder
Journal:  Clin Exp Immunol       Date:  1968-07       Impact factor: 4.330

4.  Studies into the occurrence of soluble antigen-antibody complexes in disease. VI. Further characterization of the biological and physical properties of the rheumatoid biologically active factor (RBAF).

Authors:  I Broder; E Tackaberry; M Urowitz; L Russell; R Baumal
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

5.  Inhibition of anaphylactic histamine release by Forssman antiserum. I. Characteristics of the reaction and inhibitor.

Authors:  J Duravetz; R Baumal; I Broder
Journal:  Immunology       Date:  1976-01       Impact factor: 7.397

6.  Studies into the occurrence of soluble antigen-antibody complexes in disease. IV. Correlation between the rheumatoid biologically active factor and the clinical features of rheumatoid arthritis.

Authors:  D A Gordon; D A Bell; R Baumal; I Broder
Journal:  Clin Exp Immunol       Date:  1969-07       Impact factor: 4.330

7.  DNA:anti-DNA complexes: their detection in systemic lupus erythematosus sera.

Authors:  R J Harbeck; E J Bardana; P F Kohler; R I Carr
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.